Evidence For An Increased Cancer Risk Following The Use Of Radioactive Radium-224 In The Therapy For Ankylosing Spondylitis
Jun 30th 2008Drug InformationArthritis
In the course of an epidemiological study, scientists of the Institute of Radiation Biology of the Helmholtz Zentrum Munchen German Research Center for Environmental Health have established an unfavourable benefit-risk-ratio for ankylosing spondylitis patients treated with Radium-224 therapy (Rheumatology 2008; 47: 855-59). Ankylosing Spondylitis (Bechterew’s Disease) is a painful chronic inflammatory rheumatic disease, associated with stiffening of the vertrebral column.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
